Flow Chemistry hub to boost Hyderabad pharma space

Government of Telangana to facilitate strategic support and scale-up for the hub by encouraging more industries to join the consortium and benefit from it.

Published: 26th November 2021 10:19 AM  |   Last Updated: 26th November 2021 10:19 AM   |  A+A-

Shakthi Nagappan , Director for Life Sciences and Pharma, G.V. Prasad, MD of Dr. Reddy's Laboratories, Dr. Satyanarayana Chava CEO, Laurus Labs, Dr. Srinivas Oruganti, Director, Dr. Reddy’s Institute of Life Sciences with Telangana Industries Minister KTR and Principal Secretary Jayesh Ranjan.

Telangana Minister KTR with representatives of Laurus labs and Dr. Reddy's Institute of Life Sciences during the signing of the consortium agreement, Thursday, Nov 25, 2021. (Photo | Twitter, KTR)

By Express News Service

HYDERABAD: The State government has announced the setting up of a multi-industry-supported innovation and technology hub for Flow Chemistry in Hyderabad to ensure greater incorporation of flow chemistry techniques in pharma R&D and greater adoption of continuous synthesis for manufacturing of active pharma ingredients (APIs). 

A consortium agreement for setting up the Centre of Excellence (CoE) on Flow Chemistry was signed on Thursday. This hub would function as a Centre of Excellence (CoE) and is being set up at Dr. Reddy’s Institute of Life Sciences (DRILS). It will receive funding and patronage from Dr. Reddy’s Laboratories Ltd and Laurus Labs. 

On this occasion, IT and Industries Minister, KT Rama Rao said that this hub would be an enabler for the pharma industry in India to make a paradigm shift towards the incorporation of modern approaches from R&D to manufacturing and migration to greener and sustainable processes. 

“The Government of Telangana is delighted to facilitate and support the establishment of the CoE with the help of Dr. Reddy’s Laboratories and Laurus Labs. I congratulate our life sciences team for their efforts in pulling this together,” he added.

The Government of Telangana will facilitate strategic support and scale-up for the hub by encouraging more industries to join the consortium and benefit from it. With over 800 pharmaceutical companies, Hyderabad hosts the highest number of USFDA approved facilities globally and contributes to about 35 per cent of India’s overall pharmaceutical production.


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on are those of the comment writers alone. They do not represent the views or opinions of or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp